Sleep-related epileptic spiking in early Alzheimer's disease
Description of the granted funding
Recent evidence shows that about 40% of individual with early Alzheimer's Disease (AD) display epileptic events in the brain without any visible symptoms. These have gone undetected for years, since they occur during sleep, while routine EEG is taken during daytime. Importantly, sleep-related epileptic spiking is associated with faster deterioration of the disease symptoms, especially memory. An effective and well-tolerated drug treatment of this condition may delay the need for institutional care by 2-3 years. So far no clinical drug trials have been run on sleep-related epileptic spiking in AD. This study will test most suitable type of drug treatment using a new genetic AD mouse model for this condition. In addition, we will test the idea that epileptic spiking perturbs formation of long-term memories of recent events during sleep. Finally, we will determine how often epileptic spiking really occurs by home EEG-recordings with a portable EEG-recorder.
Show moreStarting year
2021
End year
2025
Granted funding
Other information
Funding decision number
340377
Fields of science
Neurosciences
Research fields
Neurotiede
Identified topics
brain, neuroscience